14Jun 2021
Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China

Long-term safety of infants from mothers with chronic hepatitis B treated with tenofovir disoproxil in China

The physical and neuromental development of infants remains uncertain after fetal exposure to tenofovir disoproxil fumarate (TDF) for the prevention of mother-to-child transmission of HBV. We aimed to investigate the safety of TDF therapy during the third trimester of pregnancy. Infants from a previous randomised controlled trial were recruited for our long-term follow-up (LTFU) study. Mothers with chronic hepatitis B were randomised to receive TDF therapy or no treatment during the third trimester...

  • #gastroenterology

Like

Save

Share